TOP TIERMARKET NEWSWIRE
News & sentiment

SCINAI IMMUNOTHERAPE ADR (SCNI) — News & AI sentiment

SCINAI IMMUNOTHERAPE ADR (SCNI) news roundup. 2 stories in the past week, 14 over 30 days. Average 30-day sentiment is 48.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 63.5/100
30d stories
14
avg sentiment 48.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

SCNI news in the last 24 hours, 7 days, 30 days and 90 days

How much SCNI coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSCNI storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days263.5/100SCNI headlines →
Last 30 days1448.7/100SCNI headlines →
Last 90 days2650.3/100SCNI headlines →

Latest stories on SCNI

4d ago
4d ago
Oct 28
Oct 20
Oct 20
Oct 16
Oct 14
Oct 14
Oct 14
Oct 14
Oct 13
Oct 13
Oct 13
Oct 13
Sep 24
Sep 21
Sep 21
Sep 21
Sep 8
Sep 8
Sep 8
Aug 26
Aug 26
Scinai Immunotherapeutics reports 1H results
Seeking Alpha50 · neutralgeneral
Aug 24
Aug 24
Open SCNI in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →